Press & News

The MedGenome proprietary platform, currently leveraged by various commercial and academic collaborators in the US, will be presented at AACR 2016. FOSTER CITY, CALIFORNIA, UNITED STATES, March 30, 2016 /EINPresswire.com/ — MedGenome will present an abstract on its proprietary data analysis and interpretation platform for Cancer discovery research at the AACR Annual Meeting 2016, organised […]

FOSTER CITY, California, March 14, 2016 /PRNewswire/ — MedGenome presented data on its proprietary cancer immunotherapy platform, OncoPept that predicts and prioritizes T-cell neo-epitopes in human and mouse cancers at the Molecular Medicine Tri- Conference 2016, which took place on March 6 – 11, 2016 at San Francisco, CA. Many pre-clinical and clinical studies have

A comprehensive genomics study has used MedGenome’s OncoMD knowledge base to identify cancer relevant alterations in Mesothelioma, a deadly cancer. FOSTER CITY , California, March 1, 2016 /PRNewswire/ — Mesothelioma is a relatively rare cancer with a five year survival rate between five and ten percent. The global death due to Mesothelioma is estimated to be ~43,000 per year.

FOSTER CITY, California, February 24, 2016 /PRNewswire/ — MedGenome acquires the assets of Lifecode Health and its 13,000 sq ft lab in Foster City, CA to expland its genomic services to biotech and pharma companies in the US. MedGenome, the market leader for genomic diagnostics in South Asia and a leading provider of genomics research

The posters will be presented at the NGS Data Analysis and Informatics Conference, February 18–19, 2016 in San Diego, CA SAN FRANCISCO, CA, UNITED STATES, February 15, 2016 /EINPresswire.com/ — MedGenome announced today that they will present 2 posters at the NGS Data Analysis and Informatics Conference, which takes place on February 18–19, 2016 in

SAN FRANCISCO, February 2, 2016 /PRNewswire/ — MedGenome announced today that they will present more than 12 posters in the areas of oncology, metabolic disorders, neurology, rare diseases/inherited diseases and longevity/population genomics at the Advances in Genome Biology and Technology 2016, which takes place from February 10-13, 2016 in Orlando, Florida. The posters and accompanying